International Clinical Trial: A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463820) titled 'A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)' on March 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: National Cancer Institute (NCI)

Condition: Myelodysplastic Syndrome

Intervention: Procedure: Biospecimen Collection Procedure: Bone Marrow Aspiration Biological: Emavusertib Biological: Epoetin Alfa

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: June 19, 2...